Company / Accounts Receivable
Mettler Toledo Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$778.2M
FY2025
5-year range
$647.3M / $778.2M
FY2021-FY2025
Trend
+13.3%
vs FY2024
Sector context
#31 of 138
Health Care
What the data says
Mettler Toledo's accounts receivable of $778M is higher than 78% of companies in the Health Care sector (FY2025). Improved from $664M to $778M over the past 2 years.
Based on SEC 10-K filings.
$778M in FY2025 with a 5-year CAGR of +5.6%. Top quartile in the Health Care sector.
Improved from $664M to $778M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 138This company $778.2M Sector average $1.3B
▼
-41.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.6%, indicating consistent growth.
- In FY2025, accounts receivable increased 13.3% year-over-year.
- Ranks #31 out of 138 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.22 (safe zone, above 2.9 threshold)
- Strong profit margin: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $778.2M | +13.3% |
| FY2024 | $687.1M | +3.5% |
| FY2023 | $663.9M | -6.4% |
| FY2022 | $709.3M | +9.6% |
| FY2021 | $647.3M | +9.0% |
| FY2020 | $593.8M | +4.9% |
| FY2019 | $566.3M | +5.7% |
| FY2018 | $535.5M | +1.3% |
| FY2017 | $528.6M | +16.2% |
| FY2016 | $455.0M | +10.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026